Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Lancet. Oncology|August 13, 2021
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialJohann S de Bono, Niven Mehra, Giorgio V Scagliotti, et al.International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?Awalpreet S Chadha, Guan Liu, Hsiang-Chun Chen, et al.European Urology Oncology|October 31, 2025
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations-Genomic Features Associated with Response to TherapyKarim Fizazi, Johann S de Bono, A Douglas Laird, et al.Oncology|November 22, 2022
Localized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment?Maria Vassilakopoulou, Hsiang-Chun Chen, Xuemei Wang, et al.British Journal of Haematology|June 28, 2019
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patientsBoyu Hu, Keyur P Patel, Hsiang-Chun Chen, et al.Oncotarget|November 9, 2017
Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillanceElena Elimova, Rebecca S Slack, Hsiang-Chun Chen, et al.BJU International|September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohortPierre Blanchard, John W Davis, Steven J Frank, et al.British Journal of Haematology|March 30, 2019
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatmentsBoyu Hu, Keyur P Patel, Hsiang-Chun Chen, et al.British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.Oncology|April 28, 2016
Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term SurvivorsHironori Shiozaki, Rebecca S Slack, Hsiang-Chun Chen, et al.Pageof 5